PARP Inhibitor PJ34 Protects Mitochondria and Induces DNA-Damage Mediated Apoptosis in Combination With Cisplatin or Temozolomide in B16F10 Melanoma Cells

PARP-1 inhibition has recently been employed in both mono- and combination therapies in various malignancies including melanoma with both promising and contradicting results reported. Although deeper understanding of the underlying molecular mechanisms may help improving clinical modalities, the com...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Front Physiol
Hoofdauteurs: Cseh, Anna Maria, Fabian, Zsolt, Quintana-Cabrera, Ruben, Szabo, Aliz, Eros, Krisztian, Soriano, Maria Eugenia, Gallyas, Ferenc, Scorrano, Luca, Sumegi, Balazs
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Frontiers Media S.A. 2019
Onderwerpen:
Physiology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6514236/
https://ncbi.nlm.nih.gov/pubmed/31133874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphys.2019.00538
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items